Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
CASP8 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
EGFR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
ERCC6 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
FASLG - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
PIK3CA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 14 | 1 |
|
PRKN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.